GRACE STAINES: Open Payments
NPI 1134908163 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $571 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 1 | $84 |
| Novo Nordisk Inc | 3 | $68 |
| Insulet Corporation | 3 | $68 |
| Mannkind Corporation | 2 | $59 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Sequel Med Tech, LLC | 2 | $37 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| CeQur Corporation | 1 | $29 |
| Amgen Inc. | 1 | $24 |
Products named: iLet Bionic Pancreas, Omnipod, AFREZZA, RECORLEV, TWIIST, ISTURISA, Kerendia, CeQur Simplicity.
Industry payments across CT — which companies pay providers there.
